These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14725960)

  • 21. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heroin maintenance for chronic heroin-dependent individuals.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2010 Aug; (8):CD003410. PubMed ID: 20687073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heroin-assisted treatment for opioid dependence: randomised controlled trial.
    Haasen C; Verthein U; Degkwitz P; Berger J; Krausz M; Naber D
    Br J Psychiatry; 2007 Jul; 191():55-62. PubMed ID: 17602126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of ongoing oxycodone abuse among methadone-maintained patients.
    Dunn KE; Sigmon SC; McGee MR; Heil SH; Higgins ST
    J Subst Abuse Treat; 2008 Dec; 35(4):451-6. PubMed ID: 18295434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription opioid dependence and treatment with methadone in pregnancy.
    Sander SC; Hays LR
    J Opioid Manag; 2005; 1(2):91-7. PubMed ID: 17319253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life.
    Rajaratnam R; Sivesind D; Todman M; Roane D; Seewald R
    J Opioid Manag; 2009; 5(1):27-37. PubMed ID: 19344046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine abuse sharply reduced in an effective methadone maintenance program.
    Borg L; Broe DM; Ho A; Kreek MJ
    J Addict Dis; 1999; 18(4):63-75. PubMed ID: 10631964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial.
    Eiroa-Orosa FJ; Haasen C; Verthein U; Dilg C; Schäfer I; Reimer J
    Drug Alcohol Depend; 2010 Dec; 112(3):226-33. PubMed ID: 20708349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
    Peles E; Schreiber S; Rados V; Adelson M
    J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement.
    Zacny J; Bigelow G; Compton P; Foley K; Iguchi M; Sannerud C
    Drug Alcohol Depend; 2003 Apr; 69(3):215-32. PubMed ID: 12633908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Hooked on" prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients.
    Peavy KM; Banta-Green CJ; Kingston S; Hanrahan M; Merrill JO; Coffin PO
    J Psychoactive Drugs; 2012; 44(3):259-65. PubMed ID: 23061326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotherapeutic benefits of opioid agonist therapy.
    Tenore PL
    J Addict Dis; 2008; 27(3):49-65. PubMed ID: 18956529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
    Fingerhood MI; King VL; Brooner RK; Rastegar DA
    Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
    Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
    Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of buprenorphine maintenance in office-based practice.
    Magura S; Lee SJ; Salsitz EA; Kolodny A; Whitley SD; Taubes T; Seewald R; Joseph H; Kayman DJ; Fong C; Marsch LA; Rosenblum A
    J Addict Dis; 2007; 26(2):13-23. PubMed ID: 17594994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities.
    Yang J; Oviedo-Joekes E; Christian KW; Li K; Louie M; Schechter M; Spittal P
    Drug Alcohol Rev; 2011 Nov; 30(6):645-51. PubMed ID: 21355933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic.
    Weizman T; Gelkopf M; Melamed Y; Adelson M; Bleich A
    Aust N Z J Psychiatry; 2004; 38(1-2):42-6. PubMed ID: 14731193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.